Xiangyu Chen

A novel CXCL8‐IP10 hybrid protein is effective in blocking pulmonary pathology in a mouse model of Klebsiella pneumoniae infection

Hui-Yuan Yu, Hsi-Tsung Cheng, Jyawei Cheng, 2018, International immunopharmacology.

ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression and ameliorate cisplatin-induced nephrotoxicity.

B. Wang, Qiang Li, J. Gordon, 2014, Oncology reports.

G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high‑dose cisplatin-induced nephrotoxicity.

B. Wang, Qiang Li, J. Gordon, 2015, Oncology reports.

Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging

Du-jun Bian, Chengzhi Yang, Zhong He, 2014, European journal of gastroenterology & hepatology.